COCH
Income statement / Annual
Last year (2023), Envoy Medical, Inc.'s total revenue was $316,000.00,
an increase of 33.33% from the previous year.
In 2023, Envoy Medical, Inc.'s net income was -$29.91 M.
See Envoy Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$316,000.00
|
$237,000.00
|
$310,000.00
|
$0.00
|
| Cost of Revenue |
$789,000.00 |
$957,000.00 |
$769,000.00 |
$0.00 |
| Gross Profit |
-$473,000.00 |
-$720,000.00 |
-$459,000.00 |
$0.00 |
| Gross Profit Ratio |
-1.5 |
-3.04 |
-1.48 |
0 |
| Research and Development
Expenses |
$8.96 M
|
$4.52 M
|
$3.94 M
|
$0.00
|
| General & Administrative
Expenses |
$7.28 M
|
$3.47 M
|
$2.47 M
|
$0.00
|
| Selling & Marketing
Expenses |
$1.67 M
|
$885,000.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$8.94 M
|
$3.47 M
|
$2.47 M
|
$701.00
|
| Other Expenses |
$0.00 |
-$7.22 M |
-$1.80 M |
$0.00 |
| Operating Expenses |
$17.90 M |
$7.99 M |
$6.41 M |
$701.00 |
| Cost And Expenses |
$18.69 M |
$8.94 M |
$7.18 M |
$701.00 |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$133,000.00
|
$75,000.00
|
$71,000.00
|
$206,297.00
|
| EBITDA |
-$18.24 M
|
-$8.63 M
|
-$6.80 M
|
-$700.00
|
| EBITDA Ratio |
-57.72 |
-36.42 |
-21.94 |
0 |
| Operating Income Ratio
|
-58.14
|
-36.73
|
-22.16
|
0
|
| Total Other
Income/Expenses Net |
-$11.54 M
|
-$7.22 M
|
-$1.80 M
|
-$1.00
|
| Income Before Tax |
-$29.91 M |
-$15.92 M |
-$8.68 M |
-$701.00 |
| Income Before Tax Ratio
|
-94.65
|
-67.19
|
-27.98
|
0
|
| Income Tax Expense |
$0.00 |
-$153,485.00 |
-$165,558.00 |
-$206,297.00 |
| Net Income |
-$29.91 M |
-$15.92 M |
-$8.68 M |
-$701.00 |
| Net Income Ratio |
-94.65 |
-67.19 |
-27.98 |
0 |
| EPS |
-2.38 |
-1.57 |
-0.85 |
0 |
| EPS Diluted |
-2.38 |
-1.57 |
-0.85 |
0 |
| Weighted Average Shares
Out |
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Weighted Average Shares
Out Diluted |
$12.55 M
|
$10.15 M
|
$10.15 M
|
$60.38 M
|
| Link |
|
|
|
|
